-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA APPROVES ARCUTIS’ ZORYVE® (ROFLUMILAST) CREAM 0.3% FOR THE TREATMENT OF PLAQUE PSORIASIS IN CHILDREN AS YOUNG AS AGE 2

Reuters·06/29/2026 23:06:39

Please log in to view news